Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial
BackgroundIBS often appears as bloating, altered bowel patterns, and abdominal pain (AP).Probiotics and SCFA may be useful in mucosal repair and symptom relief, according to earlier research, however there is currently a lack of systematic evidence supporting their therapeutic effectiveness across a...
Saved in:
| Main Authors: | Erfeng Li, Jie Wang, Bin Guo, Wenbin Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1616066/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium butyrate in Irritable Bowel Syndrome
by: Aleksandra Kołodziej, et al.
Published: (2025-06-01) -
Isolation and Identification of the Types of Bacteria that Cause Irritable Bowel Syndrome
by: Noor Mahmood Sultan, et al.
Published: (2025-01-01) -
Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01) -
Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01) -
Sexual function, depression, and quality of life in patients with irritable bowel syndrome
by: Amir Keshavarzi, et al.
Published: (2025-07-01)